News About: Pharm. Industry
KT&G looks to future with new growth engines
KT&G, Korea’s foremost tobacco group, is busy looking for new growth engines that would empower it over the next decade.
According to KT&G officials, its affiliated company Korea Ginseng Corporation (KGC) has recen...
Boehringer Kore, Yuhan to co-market Twinsta
Boehringer Ingelheim Korea and Yuhan Corp. will jointly promote Twinsta, a combination drug of telmisartan and amlodipine, from November 1 here.
Twinsta is effective and well tolerated in a range of more complex, d...
Janssen Korea starts selling anti-AIDS drug
Janssen Korea said on November 1 it has started selling its anti-AIDS drug Prezista here after being listed in the national health insurance.
Prezistar is a second-generation protease inhibitor (PIs), designed spec...
Who will throne as top drug company?
The local pharmaceutical industry is closely watching which company will gain the number 1 ranking in terms of revenue as Dong-A Pharmaceutical struggles this year against Green Cross which succeeded in overtaking the...
Drugmakers to be hit by anti-rebate provision
The performance of Korean pharmaceutical companies will be affected in the final quarter by the government’s policy to abandon “rebates” ― a kind of kickback given by drug companies to pharmacies, clinics and hospital...
Dong-A releases new form of peripheral vasodilator
Dong-A Pharmaceutical Co. says it will supply new package of Opalmon (limaprost), peripheral vasodilator, from November 1, as its price was reduced by 20 percent. Limaprost, an alprostadil (prostaglandin E1) analogue,...
Biospace veers into smart care market
Biospace Co. will enter the local smart care market together with LG Electronics backed by the government, officials said recently.
The Ministry of Knowledge Economy said it would inject 51.4 billion won to carry o...
Rising development costs of biosimilars make US market entry difficult proposition
Clearing the U.S. regulatory hurdles is expected to be an arduous exercise for Korean firms, said President Song Byung-doo of Scripps Korea Antibody Institute (SKAI).
In a local SKAI symposium, Song said that Biosi...
Natural vitamins gain high popularity
A significant number of the vitamins you will find on the pharmacy shelves these days are made synthetically through chemical processes, rather than derived directly from plants or other materials, although some manuf...
Green Cross still tops No.1 in accumulated sales
In terms of accumulated revenue up to the third quarter of this year, Green Cross Corp. ranked first with 639.4 billion won, followed by Dong-A Pharmaceutical with 634.4 billion won.
Green Cross posted revenues of ...
